Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent versus sequential anastrozole with adjuvant radiotherapy for hormone receptor-positive breast cancer
ACTRN12610000307000Phase 3Active, not recruiting
- Sponsor
- Assoc. Prof. Peter Graham
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of anastrozole in breast cancer, sponsored by Assoc. Prof. Peter Graham. Started Sep 2009; status: active, not recruiting.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12610000307000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000307000.